1. Introducing the New PREVENTEST™ from GeneID
Advanced Molecular Diagnostics, LLC
 PrevenTest is a non-invasive cancer risk pre-disposition test
analyzing 31 genes linked to 8 of the most prevalent and
devastating solid tumor hereditary cancers:
Breast, Ovarian, Colorectal, Endometrial, Prostate,
Pancreas, Stomach and Skin
 Testing additional actionable genes beyond BRCA1 &
BRCA2 increases the detection of cancer-causing
mutations by 43% (Cancer, 2015 pp 25-33)
 Hereditary Cancer Risk predictive testing is covered by
Medicare and many insurance plans
Genetic Consultation services are available for test result
analysis and preventative planning

Test performed with a simple buccal (cheek) swab
Results returned within 7-9 business days after insurance
verification, via HIPAA compliant email, fax and hard copy

